Nanoparticles-mediated CRISPR/Cas9 delivery: Recent advances in cancer treatment

Clustered regularly interspaced short palindromic repeat-CRISPR-associated protein (CRISPR-Cas) genome-editing systems, prokaryotic adaptive immune system, have been exploited and prepared a robust programmable method for efficient and accurate genome editing and gene targeting. This revolutionary technique can be used for engineered cell therapies, in vivo gene therapy, animal modeling, and cancer diagnosis and treatment. Recently, safe and...